Research ArticleHead & Neck
Posttreatment Imaging in Patients with Head and Neck Cancer without Clinical Evidence of Recurrence: Should Surveillance Imaging Extend Beyond 6 Months?
A. Gore, K. Baugnon, J. Beitler, N.F. Saba, M.R. Patel, X. Wu, B.J. Boyce and A.H. Aiken
American Journal of Neuroradiology July 2020, 41 (7) 1238-1244; DOI: https://doi.org/10.3174/ajnr.A6614
A. Gore
aFrom the Departments of Radiology and Imaging Sciences (A.G., K.B., X.W., A.H.A.)
K. Baugnon
aFrom the Departments of Radiology and Imaging Sciences (A.G., K.B., X.W., A.H.A.)
J. Beitler
bRadiation Oncology (J.B.)
N.F. Saba
cHematology/Oncology (N.F.S.)
dOtolaryngology (N.F.S., M.R.P., B.J.B., A.H.A.), Emory University School of Medicine, Atlanta, Georgia.
M.R. Patel
dOtolaryngology (N.F.S., M.R.P., B.J.B., A.H.A.), Emory University School of Medicine, Atlanta, Georgia.
X. Wu
aFrom the Departments of Radiology and Imaging Sciences (A.G., K.B., X.W., A.H.A.)
B.J. Boyce
dOtolaryngology (N.F.S., M.R.P., B.J.B., A.H.A.), Emory University School of Medicine, Atlanta, Georgia.
A.H. Aiken
aFrom the Departments of Radiology and Imaging Sciences (A.G., K.B., X.W., A.H.A.)
dOtolaryngology (N.F.S., M.R.P., B.J.B., A.H.A.), Emory University School of Medicine, Atlanta, Georgia.
Advertisement